Quest Partners LLC Enanta Pharmaceuticals Inc Transaction History
Quest Partners LLC
- $753 Billion
- Q4 2024
A detailed history of Quest Partners LLC transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Quest Partners LLC holds 22,260 shares of ENTA stock, worth $160,717. This represents 0.02% of its overall portfolio holdings.
Number of Shares
22,260
Previous 19,123
16.4%
Holding current value
$160,717
Previous $198 Million
35.39%
% of portfolio
0.02%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding ENTA
# of Institutions
108Shares Held
19.7MCall Options Held
9.7KPut Options Held
12.4K-
Krensavage Asset Management, LLC New York, NY2.12MShares$15.3 Million7.2% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.11MShares$15.2 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.98MShares$14.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.85MShares$13.3 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.22MShares$8.82 Million0.0% of portfolio
About ENANTA PHARMACEUTICALS INC
- Ticker ENTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,724,900
- Market Cap $150M
- Description
- Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...